Under Armour valuation leaves us on sidelines, says Susquehanna Susquehanna is cautious near-term on Under Armour as they believe Street Q1 numbers seem to underestimate needed investments. The firm expects estimates to be lowered but sees the company as well positioned for the long-term citing product innovation, and opportunities both domestically and internationally. Shares are Neutral rated with a $77 price target.
News For UA From The Last 14 Days
Check below for free stories on UA the last two weeks.
On The Fly: Analyst Upgrade Summary Today's noteworthy upgrades include: AB InBev (BUD) upgraded to Hold from Sell at Societe Generale... Baker Hughes (BHI) upgraded to Outperform from Sector Perform at Howard Weil... Bank of the Ozarks (OZRK) upgraded to Buy from Hold at BB&T... Bill Barrett (BBG) upgraded to Buy from Neutral at Mizuho... Cepheid (CPHD) upgraded to Buy from Hold at Cantor... Cigna (CI) upgraded to Positive from Neutral at Susquehanna... Extra Space Storage (EXR) upgraded to Buy from Hold at Jefferies... GNC Holdings (GNC) upgraded to Outperform from Neutral at Wedbush... MB Financial (MBFI) upgraded at DA Davidson... Mondelez (MDLZ) upgraded to Buy from Hold at Societe Generale... Radian Group (RDN) upgraded to Buy from Neutral at Compass Point... Skullcandy (SKUL) assumed with a Overweight from Neutral at Piper Jaffray... Under Armour (UA) upgraded to Overweight from Neutral at Piper Jaffray.